Sign in →

Test Code EBVP EBV Antibody Panel

Important Note

Testing at Munson Medical Laboratories coming soon!  Order Mayo sendout test EBVAB EBVAB - Overview: Epstein-Barr Virus Antibody Profile, Serum

EHR Test Codes

  Test Code Test Name
Atlas EBVP EBV Antibody Panel
Cerner   EBV Antibody Panel

Specimen Requirements

Preparation of Patient: 

None

 

Container Type: 

Gold Top 6mL SST Gel & Clot Activator Tube

Specimen Type:

Serum

 

Specimen Volume: 

2.5 mL Serum minimum 0.3 mL

 

Specimen Handling/Transport:

Transport refrigerated 2 - 8°C

 

Specimen Stability/Storage:

 2 days refrigerated 2 - 8°C

 

Specimen Rejection:

Gross hemolysis

Gross lipemia

Gross icterus

Performing Laboratory

Munson Medical Center Laboratories

Chemistry Department

Priority, Frequency, & Turnaround

Priority:

Non-Emergent

 

Frequency:

Wednesday

 

Turnaround:

0 - 7 days

Methodology

Chemiluminescence Immunoassay

 

Panel Includes: EBV, IgM, Early Antigen (EA IgG), Epstein-Barr Nuclear Antigen (EBNA), and Viral Capsid Antigen (VCA, IgG)

Reporting

Reference Range:

Negative

 

Interpretive Data:

Equivocal sample should be repeat tested.  In case the result remains in the range after repeat testing, a second sample should  be collected and tested no less than one or two weeks later.

 

Flow Diagram:

The accurate distinction of a primary (acute) infection from seronegative status or past infection is a key concern of EBV diagnostics. The presence of other EBV serological markers (e.g. EBV IgM, VCA IgG, EBNA IgG) should be determined to assess the immunological status to infection with EBV. Based on the results of three commonly-used antibody tests (VCA IgG, EBV IgM, EBNA IgG), distinct serological profiles have been described in the medical literature.

 

Condition VCA IgG EBV IgM EBNA IgG
EBV seronegative - - -
Primary (acute) infection + + -
Past infection + - _
Indeterminate      
VCA IgG only + - -
EBV IgM only - + -
EBNA IgG only - - +
Convalescent + + +

 

Because some individuals are reported to exhibit long-lasting EBV IgM antibodies, the convalescent pattern may represent a transient period late in the primary infection stage or may persist well into the past infection stage. Thus, it is considered an indeterminate pattern. For samples that exhibit indeterminate patterns, further diagnostic testing may be required. In all cases, diagnosis of infectious diseases should not be established on the basis of a single test result, but should be determined in conjunction with clinical findings and other diagnostic procedures as well as in association with medical judgment

 

Critical Decision: 

None

Clinical Significance

Epstein-Barr virus (EBV) is responsible for infectious mononucleosis (IM) and is implicated in Burkitt's lymphoma and nasopharyngeal carcinoma.  Antibody response profiles for the different EBV antigens demonstrate a characteristic pattern for silent primary or persistent latent EBV infections, as well as for each of the EBV-associated diseases.

CPT Code(s)

86663

86664

86665